Buyout Funds
- ABRY Heritage Partners
- ABRY Partners VI
- ABRY Partners VII
- ABRY Partners VIII
- ABRY Partners IX
- ALPHA CEE II
- Avista Capital Partners
- Avista Capital Partners II
- Avista Capital Partners III
- Avista Capital Partners IV
- BI-Invest Endowment Fund
- Bridgepoint Europe IV
- Capvis Equity III
- Cinven VII
- Clayton, Dubilier and Rice Fund VI
- Eagletree Partners III
- Eagletree Partners IV
- Industri Kapital 2007 Fund
- Investidustrial IV
- Investindustrial V
- Investindustrial VI
- Investindustrial VII
- Mid Europa Fund IV
- Mid Europa Fund V
- Pollen Street Capital III
- Procuritas Capital Investors VI
- TA Associates XIII
- Warburg Pincus China-Southeast Asia II
- Warburg Pincus X (global expansion capital)
- Warburg Pincus XII
Venture Funds
- Boulder Ventures IV
- CDC Innovation 2000
- Clarus Lifesciences III
- Clarus IV
- Emerging Managers Program
- Evolution Technology
- Growth Fund I
- Growth Fund II
- Growth Fund III
- Growth Fund IV
- Highland Europe I
- Highland Europe II
- Highland Europe III
- Institutional Venture Partners XII
- Institutional Venture Partners XIII
- Kennet III
- Life Sciences Fund
- Pelion IV
- Pelion V
- Pelion VI
- TAT Investments I
- Undisclosed Growth Fund I
- Undisclosed Growth Fund II
- Undisclosed Growth Fund III
Special Situation Funds
- ABRY Advanced Securities Fund I
- ABRY Advanced Securities Fund III
- ABRY Advanced Securities Fund IV
- ABRY Senior Equity IV
- ABRY Senior Equity V
- ALPHA CEE Opportunity IV
- ALPHA Russia & CIS Secondary
- DB Secondary Opportunities Fund A
- DB Secondary Opportunities Fund C
- HIG Middle Market LBO III
- OCM European Principal Opportunities Fund II
- OCM Opportunities Fund VII
- OCM Opportunities Fund VIIb
- Sycamore Partners II
- Sycamore Partners III
- WL Ross Recovery Fund IV